Financial report interval: 2025.12.31 - 2026.03.31
Preview: Anaptysbio(ANAB) predict that the Revenue is 25.56 M (-7.98%), Beat estimate;the EBIT is -34.64 M (-25.77%), Miss estimate;the EPS is -1.84 (-43.75%), Miss estimate.